Track record · closed signal

Webster Financial Corporation (WBS) — closed signal from October 27, 2025

Target reached Published before the outcome was known, scored automatically when the window closed on January 25, 2026.

Predicted vs. what happened

WBS price · publication thesis → realized outcomesplit-adjusted

$55.22 – $56.70Entry zone — fair-value band

$57.13Published — price the day we called it

$68.08Target — the price the thesis aimed for

$67.43Peak — highest point inside the window, not a realized return

$66.22Window close — end-of-window price, context only

What happened

Target reached

Hit or exceeded the predicted growth inside the window.

Peak price

$67.43

peak on January 22, 2026 — not a realized return

Peak gain

+18%

peak, from the publication price

Window close

$66.22

end-of-window price, context only

Days to target

—

Window

October 27, 2025 – January 25, 2026

The thesis — published October 27, 2025

Predicted growth

+20%

over the measurement window

Target price

$68.08

the price the thesis aimed for

Entry zone

$55.22 – $56.70

the fair-value band we waited for

Price at publication

$57.13

published October 27, 2025

Confidence

81%

how strongly the data lined up

Timeframe

Short-term (0–3 months)

Webster's latest quarter beat expectations, with profit per share at 1.54 dollars and loans growing. It also spent 131.2 million dollars buying its own stock, which can help the price. Management said interest income may dip soon and deposits can seasonally flow out, but the core business and health savings account unit are steady. Over the next 3 months, buying small pullbacks with care looks reasonable.

Primary drivers

Recent quarter beat expectations; profits grew and momentum improved
Company bought back $131.2M of its own shares, aiding price support
Investors are more positive after results, drawing more buyers
Health savings account business adds steady, reliable fee income

How it played out

WBS: thesis rose but missed the target

Lyra published WBS at 57.13 on 2025-10-27, with a short-term thesis for 20% expected growth. The thesis pointed to a recent quarter that beat expectations, profit per share of 1.54 dollars, loan growth, a 131.2 million dollar buyback, improved investor interest after results, and steady fee income from the health savings account business.

Inside the window through 2026-01-25, WBS rose to 67.43 on 2026-01-22, a peak gain of 18%. It stayed below the 68.08 target and never reached it. The stock ended at 66.22. The thesis mostly played out on price direction, but it missed the published target.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All WBS signals